|
EXP000815
|
Structure-activity relationship study of Aib-containing amphipathic helical pep…
|
2017 |
PV
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000816
|
Structure-activity relationship study of Aib-containing amphipathic helical pep…
|
2017 |
PVI
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000817
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4
|
mRNA
|
no |
yes |
yes |
no |
no |
|
EXP000818
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-L0
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000819
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-L1
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000820
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-L2
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000821
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-L3
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000822
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-L4
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000823
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-L5
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000824
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-L6
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000825
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A1
|
mRNA
|
no |
yes |
yes |
no |
no |
|
EXP000826
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A2
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000827
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A3
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000828
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A4
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000829
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A5
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000830
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A6
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000831
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A1-Trp2
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000832
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A1-Tyr2
|
mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000833
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A1-Sali
|
mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000834
|
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovaria…
|
2023 |
MLP1
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000835
|
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovaria…
|
2023 |
MLP2
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000836
|
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovaria…
|
2023 |
MLP3
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000837
|
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovaria…
|
2023 |
MLP4
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000838
|
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovaria…
|
2023 |
MLP5
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000839
|
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovaria…
|
2023 |
MLP6
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000840
|
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovaria…
|
2023 |
MLP4
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000841
|
MicroRNA delivery by arginine-rich cell-penetrating peptides: An investigation …
|
2024 |
MR
|
plasmid DNA (pDNA; miRNA expression)
|
yes |
yes |
|
no |
no |
|
EXP000842
|
MicroRNA delivery by arginine-rich cell-penetrating peptides: An investigation …
|
2024 |
R9
|
plasmid DNA (pDNA; miRNA expression)
|
yes |
yes |
|
no |
no |
|
EXP000843
|
Induction of splice correction by cell-penetrating peptide nucleic acids
|
2006 |
Tat
|
PNA (splice-switching antisense)
|
yes |
yes |
yes |
no |
no |
|
EXP000844
|
Induction of splice correction by cell-penetrating peptide nucleic acids
|
2006 |
Penetratin
|
PNA (splice-switching antisense)
|
yes |
yes |
yes |
no |
no |
|
EXP000845
|
Induction of splice correction by cell-penetrating peptide nucleic acids
|
2006 |
Transportan
|
PNA (splice-switching antisense)
|
yes |
yes |
yes |
no |
no |
|
EXP000846
|
Induction of splice correction by cell-penetrating peptide nucleic acids
|
2006 |
Tat
|
PNA (splice-switching antisense)
|
yes |
no |
yes |
no |
no |
|
EXP000847
|
Induction of splice correction by cell-penetrating peptide nucleic acids
|
2006 |
Penetratin
|
PNA (splice-switching antisense)
|
yes |
no |
yes |
no |
no |
|
EXP000848
|
Induction of splice correction by cell-penetrating peptide nucleic acids
|
2006 |
Transportan
|
PNA (splice-switching antisense)
|
yes |
no |
yes |
no |
no |
|
EXP000857
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000858
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
R8
|
mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000859
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000860
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000861
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000862
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
R8
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000863
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000864
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000865
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP000866
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
R8
|
mRNA
|
no |
|
|
yes |
no |
|
EXP000867
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
no |
|
|
yes |
no |
|
EXP000868
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
no |
|
|
yes |
no |
|
EXP000869
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP000870
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
no |
|
|
yes |
no |
|
EXP000871
|
Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–a…
|
2008 |
compound 1
|
PMO
|
yes |
yes |
yes |
no |
no |
|
EXP000872
|
Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–a…
|
2008 |
compound 3
|
PMO
|
yes |
yes |
|
no |
no |
|
EXP000873
|
Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–a…
|
2008 |
compound 5
|
PMO
|
yes |
yes |
yes |
no |
no |
|
EXP000874
|
Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–a…
|
2008 |
compound 7
|
PMO
|
yes |
yes |
|
no |
no |
|
EXP000875
|
Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–a…
|
2008 |
compound 8
|
PMO
|
yes |
yes |
|
no |
no |
|
EXP000876
|
Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–a…
|
2008 |
compound 9
|
PMO
|
no |
yes |
yes |
no |
no |
|
EXP000877
|
Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–a…
|
2008 |
compound 10
|
PMO
|
yes |
yes |
|
no |
no |
|
EXP000878
|
Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–a…
|
2008 |
compound 11
|
PMO
|
yes |
yes |
|
no |
no |
|
EXP000879
|
Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–a…
|
2008 |
compound 13
|
PMO
|
yes |
yes |
|
no |
no |
|
EXP000880
|
Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–a…
|
2008 |
(R-AbuL-R)3
|
PMO
|
no |
yes |
|
no |
no |
|
EXP000881
|
Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–a…
|
2008 |
R8 (Arg8)
|
PMO
|
no |
|
yes |
no |
no |
|
EXP000882
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
KLA (MAP)
|
PNA (peptide nucleic acid)
|
no |
yes |
yes |
no |
no |
|
EXP000883
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
KGL
|
PNA (peptide nucleic acid)
|
no |
yes |
|
no |
no |
|
EXP000884
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
KAL
|
PNA (peptide nucleic acid)
|
no |
yes |
|
no |
no |
|
EXP000885
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
ELA
|
PNA (peptide nucleic acid)
|
no |
no |
|
no |
no |
|
EXP000886
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
RLA
|
PNA (peptide nucleic acid)
|
no |
yes |
|
no |
no |
|
EXP000887
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
Penetratin
|
PNA (peptide nucleic acid)
|
no |
no |
|
no |
no |
|
EXP000888
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
KLA (MAP)
|
PNA (peptide nucleic acid)
|
no |
yes |
yes |
no |
no |
|
EXP000889
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
KLA (MAP)
|
PNA (peptide nucleic acid)
|
yes |
yes |
yes |
no |
no |
|
EXP000890
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
KLA (MAP)
|
PNA (peptide nucleic acid)
|
no |
no |
|
no |
no |
|
EXP000891
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
KLA (MAP)
|
PNA (peptide nucleic acid)
|
no |
no |
|
no |
no |
|
EXP000892
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
KGL
|
PNA (peptide nucleic acid)
|
no |
yes |
|
no |
no |
|
EXP000893
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
KAL
|
PNA (peptide nucleic acid)
|
no |
yes |
|
no |
no |
|
EXP000894
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
ELA
|
PNA (peptide nucleic acid)
|
no |
no |
|
no |
no |
|
EXP000895
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
ELA
|
PNA (peptide nucleic acid)
|
no |
no |
|
no |
no |
|
EXP000896
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
RLA
|
PNA (peptide nucleic acid)
|
no |
yes |
yes |
no |
no |
|
EXP000897
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
Penetratin
|
PNA (peptide nucleic acid)
|
no |
yes |
yes |
no |
no |
|
EXP000898
|
Structural Requirements for Cellular Uptake and Antisense Activity of Peptide N…
|
2006 |
Penetratin
|
PNA (peptide nucleic acid)
|
yes |
yes |
yes |
no |
no |
|
EXP000899
|
Cell-penetrating peptides for siRNA delivery to glioblastomas
|
2018 |
PF51 (PepFect 51)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP000900
|
Cell-penetrating peptides for siRNA delivery to glioblastomas
|
2018 |
PF52 (PepFect 52)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP000901
|
Cell-penetrating peptides for siRNA delivery to glioblastomas
|
2018 |
PF53 (PepFect 53)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP000902
|
Cell-penetrating peptides for siRNA delivery to glioblastomas
|
2018 |
PF14 (PepFect 14)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP000903
|
Cell-penetrating peptides for siRNA delivery to glioblastomas
|
2018 |
PF14:TG1 (non-covalent)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP000904
|
Cell-penetrating peptides for siRNA delivery to glioblastomas
|
2018 |
PF14:TG2 (non-covalent)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP000905
|
Cell-penetrating peptides for siRNA delivery to glioblastomas
|
2018 |
PF14:TG3 (non-covalent)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP000906
|
Cell-penetrating peptides for siRNA delivery to glioblastomas
|
2018 |
PF14:TG4 (non-covalent)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP000907
|
Cell-penetrating peptides for siRNA delivery to glioblastomas
|
2018 |
PF32 (PepFect 32)
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000908
|
Cell-penetrating peptides for siRNA delivery to glioblastomas
|
2018 |
PF38 (PepFect 38)
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000909
|
Cell-Penetrating Peptides and Peptide Nucleic Acid-Coupled MRI Contrast Agents:…
|
2009 |
D-Tat57-49 (retro-inverso Tat)
|
PNA
|
yes |
no |
no |
no |
no |
|
EXP000910
|
Cell-Penetrating Peptides and Peptide Nucleic Acid-Coupled MRI Contrast Agents:…
|
2009 |
D-Tat57-49 (retro-inverso Tat)
|
PNA
|
no |
|
|
yes |
no |
|
EXP000911
|
Cell-Penetrating Peptides and Peptide Nucleic Acid-Coupled MRI Contrast Agents:…
|
2009 |
D-Tat57-49 (retro-inverso Tat)
|
PNA
|
yes |
no |
no |
no |
no |
|
EXP000912
|
Identification of a Short Cell-Penetrating Peptide from Bovine Lactoferricin fo…
|
2016 |
L5a (LFcin-derived penta-peptide)
|
plasmid DNA
|
yes |
yes |
|
no |
no |
|
EXP000913
|
Identification of a Short Cell-Penetrating Peptide from Bovine Lactoferricin fo…
|
2016 |
L5a (LFcin-derived penta-peptide)
|
plasmid DNA
|
yes |
yes |
|
no |
no |
|
EXP000914
|
Identification of a Short Cell-Penetrating Peptide from Bovine Lactoferricin fo…
|
2016 |
L6 (bLFcin6; LFcin-derived hexa-peptide)
|
plasmid DNA
|
yes |
yes |
|
no |
no |
|
EXP000915
|
Identification of a Short Cell-Penetrating Peptide from Bovine Lactoferricin fo…
|
2016 |
L6 (bLFcin6; LFcin-derived hexa-peptide)
|
plasmid DNA
|
yes |
yes |
|
no |
no |
|
EXP000916
|
A convergent uptake route for peptide- and polymer-based nucleotide delivery sy…
|
2015 |
PepFect 6 (PF6)
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP000917
|
A convergent uptake route for peptide- and polymer-based nucleotide delivery sy…
|
2015 |
PepFect 14 (PF14)
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP000918
|
A convergent uptake route for peptide- and polymer-based nucleotide delivery sy…
|
2015 |
dPF14 (all-D analog of PF14)
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP000919
|
A convergent uptake route for peptide- and polymer-based nucleotide delivery sy…
|
2015 |
s-RxR4 (stearylated (RxR)4)
|
plasmid DNA
|
no |
yes |
|
no |
no |
|
EXP000920
|
A convergent uptake route for peptide- and polymer-based nucleotide delivery sy…
|
2015 |
PepFect 6 (PF6)
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP000921
|
A convergent uptake route for peptide- and polymer-based nucleotide delivery sy…
|
2015 |
CADY
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP000922
|
A convergent uptake route for peptide- and polymer-based nucleotide delivery sy…
|
2015 |
PF14-Fl (fluorescent PF14 analog)
|
siRNA
|
yes |
no |
|
no |
no |